NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that its revenues for the first quarter of fiscal year 2019 fell 21 percent year over year.

For the three months ended Oct. 31, the firm reported total revenues of $21.3 million, down from $26.9 million in Q1 2018.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.